日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies

SGLT2抑制剂与GLP-1受体激动剂联合治疗2型糖尿病患者的有效性和安全性：队列研究的系统评价和荟萃分析

期刊:Diabetologia
影响因子:10.2
doi:10.1007/s00125-025-06565-6
Colombijn, Julia M T; de Leijer, Jan F; Visseren, Frank L J; Verhaar, Marianne C; van Raalte, Daniël H; Sattar, Naveed; Vernooij, Robin W M; van Sloten, Thomas T
SGLT2
GLP-1
信号转导
代谢
糖尿病
发表日期：2026
文献求助 收藏

Using SCORE2 with a risk chart or online calculator: impact on model performance, treatment eligibility, and cardiovascular disease prevention

将 SCORE2 与风险图表或在线计算器结合使用：对模型性能、治疗资格和心血管疾病预防的影响

期刊:European Heart Journal-Quality of Care and Clinical Outcomes
影响因子:4.6
doi:10.1093/ehjqcco/qcaf122
Hageman, Steven H J; Kaptoge, Stephen; Gynnild, Mari N; Holtrop, Joris; Pennells, Lisa; McEvoy, J William; Bobak, Martin; Pająk, Andrzej; Pikhart, Hynek; Tamosiunas, Abdonas; Smulders, Yvo M; Mach, Francois; Carballo, David; Steyerberg, Ewout W; Dorresteijn, Jannick A N; Di Angelantonio, Emanuele; Wood, Angela M; Visseren, Frank L J
心血管疾病
心血管
发表日期：2026
文献求助 收藏

Mutation-Specific Response to Ramucirumab in EGFR-Mutated Metastatic NSCLC: Insights From Circulating Cell-Free DNA Profiling (Liquid Biopsy Japan Addendum of RELAY Phase 3 Randomized Study)

EGFR 突变转移性非小细胞肺癌对雷莫芦单抗的突变特异性反应：来自循环游离 DNA 分析的启示（RELAY 3 期随机研究的液体活检日本附录）

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2026.100963
Nishio, Kazuto; Sakai, Kazuko; Nishio, Makoto; Seto, Takashi; Visseren-Grul, Carla; Carlsen, Michelle; Enatsu, Sotaro; Matsui, Tomoko; Nakagawa, Kazuhiko
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2026
文献求助 收藏

SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in KRAS G12C NSCLC

SUNRAY-01试验方案：一项创新性的研究设计，旨在评估奥洛莫拉西布和帕博利珠单抗联合或不联合化疗治疗KRAS G12C非小细胞肺癌的疗效。

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2026.2651961
Peters, Solange; Hochmair, Maximilian; Arbour, Kathryn C; Rodriguez, Luis Paz-Ares; Reck, Martin; Leal, Ticiana; R Lindsay, Colin; Shun, Lu; William, William Nassib; Spira, Alexander I; Sabari, Joshua K; Henning Grønberg, Bjørn; Nishio, Makoto; Burns, Timothy F; Girard, Nicolas; Capuzzo, Frederico; Merced, Alyson; Fasnacht, Nicolas; Visseren-Grul, Carla; Negrao, Marcelo V
肺癌
肿瘤
肿瘤免疫
细胞生物学
RAS
发表日期：2026
文献求助 收藏

Relation Between Adiposity Measures and the Risk of a Composite of Cardiovascular Events, Diabetes, and Cancer in Patients With Cardiovascular Disease

肥胖指标与心血管疾病患者心血管事件、糖尿病和癌症复合风险之间的关系

期刊:Clinical Obesity
影响因子:2.1
doi:10.1111/cob.70064
Bhattacharya, Ritobrata; Visseren, Frank L J; van der Meer, Manon G; Teraa, Martin; Dorresteijn, Jannick A N; Ruigrok, Ynte M; van Sloten, Thomas T
心血管疾病
糖尿病
心血管
肿瘤
肥胖
代谢
肿瘤免疫
发表日期：2026
文献求助 收藏

Risk prediction of cardiovascular disease in the Asia-Pacific region: the SCORE2 Asia-Pacific model

亚太地区心血管疾病风险预测：SCORE2亚太模型

期刊:European Heart Journal
影响因子:35.6
doi:10.1093/eurheartj/ehae609
Hageman, Steven H J; Huang, Zijuan; Lee, Hokyou; Kaptoge, Stephen; Dorresteijn, Jannick A N; Pennells, Lisa; Di Angelantonio, Emanuele; Visseren, Frank L J; Kim, Hyeon Chang; Johar, Sofian
心血管疾病
心血管
发表日期：2025
文献求助 收藏

Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease: A clinical consensus statement of the ESC Council on Cardiovascular Genomics, the ESC Cardiovascular Risk Collaboration, and the European Association of Preventive Cardiology

多基因风险评分在预测心血管疾病中的临床应用及实施：欧洲心脏病学会心血管基因组学委员会、欧洲心脏病学会心血管风险协作组和欧洲预防心脏病学会的临床共识声明

期刊:European Heart Journal
影响因子:35.6
doi:10.1093/eurheartj/ehae649
Schunkert, Heribert; Di Angelantonio, Emanuele; Inouye, Michael; Patel, Riyaz S; Ripatti, Samuli; Widen, Elisabeth; Sanderson, Saskia C; Kaski, Juan Pablo; McEvoy, John W; Vardas, Panos; Wood, Angela; Aboyans, Victor; Vassiliou, Vassilios S; Visseren, Frank L J; Lopes, Luis R; Elliott, Perry; Kavousi, Maryam
心脏病
心血管疾病
心血管
发表日期：2025
文献求助 收藏

Applicability of guideline-informing lipid-lowering clinical trials to contemporary real-world patients with atherosclerotic cardiovascular disease

指导性降脂临床试验对当代真实世界中患有动脉粥样硬化性心血管疾病患者的适用性

期刊:European Heart Journal-Quality of Care and Clinical Outcomes
影响因子:4.6
doi:10.1093/ehjqcco/qcaf091
Schuitema, Pauline C E; Stam-Slob, Manon C; Visseren, Frank L J; Koopal, Charlotte
心血管疾病
心血管
动脉粥样硬化
发表日期：2025
文献求助 收藏

The relationship between the EAT-Lancet dietary pattern and risk of cardiovascular events in patients with established cardiovascular disease

EAT-Lancet饮食模式与已确诊心血管疾病患者心血管事件风险之间的关系

期刊:European Journal of Nutrition
影响因子:4.3
doi:10.1007/s00394-025-03754-2
Hoes, Lukas L F; Colizzi, Chiara; van der Schouw, Yvonne T; Geleijnse, Johanna M; Dorresteijn, Jannick A N; van der Meer, Manon G; Teraa, Martin; Visseren, Frank L J; Koopal, Charlotte
心血管疾病
心血管
发表日期：2025
文献求助 收藏

RELAY+: Final Overall Survival With Ramucirumab Plus Gefitinib in Patients With Untreated EGFR-Mutated Metastatic NSCLC

RELAY+：雷莫芦单抗联合吉非替尼治疗未经治疗的EGFR突变转移性非小细胞肺癌患者的最终总生存期

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2025.100912
Nishio, Makoto; Seto, Takashi; Reck, Martin; Garon, Edward B; Nishio, Kazuto; Kasahara, Kazuo; Nishino, Kazumi; Satouchi, Miyako; Yoh, Kiyotaka; Hayashi, Hidetoshi; Sakai, Kazuko; Enatsu, Sotaro; Matsui, Tomoko; Varughese, Sunoj Chacko; Carlsen, Michelle; Visseren-Grul, Carla; Nakagawa, Kazuhiko
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2025
文献求助 收藏